Pharmacological mechanism of xanthoangelol underlying Nrf-2/TRPV1 and anti-apoptotic pathway against scopolamine-induced amnesia in mice.
Alzheimer Disease
/ drug therapy
Amnesia
/ chemically induced
Animals
Antioxidants
/ pharmacology
Chalcone
/ analogs & derivatives
GA-Binding Protein Transcription Factor
/ metabolism
Hydrogen Peroxide
/ metabolism
Maze Learning
Mice
Neuroprotective Agents
Oxidative Stress
Scopolamine
/ pharmacology
TRPV Cation Channels
/ metabolism
Alzheimer’s disease
Apoptosis
Neurodegeneration
Neuroprotection
Oxidative stress
Xanthoangelol
Journal
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
11
02
2022
revised:
26
04
2022
accepted:
29
04
2022
entrez:
5
6
2022
pubmed:
6
6
2022
medline:
9
6
2022
Statut:
ppublish
Résumé
Alzheimer's disease (AD) is a well-known type of age-related dementia. The present study was conducted to investigate the effect of xanthoangelol against memory deficit and neurodegeneration associated with AD. Preliminarily, xanthoangelol produced neuroprotective effect against H
Identifiants
pubmed: 35658216
pii: S0753-3322(22)00462-0
doi: 10.1016/j.biopha.2022.113073
pii:
doi:
Substances chimiques
Antioxidants
0
GA-Binding Protein Transcription Factor
0
Neuroprotective Agents
0
TRPV Cation Channels
0
TRPV1 protein, mouse
0
Chalcone
5S5A2Q39HX
xanthoangelol
62949-76-2
Hydrogen Peroxide
BBX060AN9V
Scopolamine
DL48G20X8X
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
113073Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.